Shakeri, A., and C. Adanty. “Romosozumab (sclerostin Monoclonal Antibody) for the Treatment of Osteoporosis in Postmenopausal Women: A Review”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 27, no. 1, Jan. 2020, pp. e25-e31, doi:10.15586/jptcp.v27i1.655.